2015年4月22~26日，第50届欧洲肝脏研究学会(EASL)年会暨国际肝脏大会(The International Liver Congress?，ILC 2015)将在奥地利维也纳举行。

        今年EASL创建已历经50载，会议主办方将隆重纪念这一历史性时刻，与此同时，也热烈祝贺学会期刊Journal of Hepatology杂志在最新公布的影响因子破10--在肝病领域杂志中名列前茅!

        大会名誉主席Serge Erlinger教授介绍道，“维也纳是ILC 2015举办最理想的城市。在这里，诞生了被誉为‘现代肝病学之父’的汉斯·波普尔(Hans Popper，1903~1988年)--世界著名的肝病学家与病理学家，肝病学领域的重要奠基人之一，他筹建了美国肝病研究学会(AASLD)和国际肝病学会。我相信本届大会将取得一个巨大的成功!”

        大会两点抢先看

        2015/4/22 星期三

        8:00 - 8:30 Joint Workshop: ILC Viral Hepatitis Workshop

        ●Is HBV infection curable? Fabien Zoulim, France

        ●Challenge: the HCC epidemics in ?cured? hepatitis patients Jordan Feld, Canada

        ●HCV treatment to PWID-results from the ACTIVATE trial Stéphane Chevaliez, France

        10:00 - 10:15 Joint Workshop: EASL-Public Health CAG

        ●Current and future options to treat high risk groups and difficult to treat patients: Chronic HBV Maurizia Brunetto, Italy

        ●Current and future options to treat high risk groups and difficult to treat patients: Chronic HCV Jason Grebely, Australia

        ●Prospects for an effective HCV vaccine Thomas Baumert, France

        11:30 - 17:30 Post-Graduate Course--Metabolic Liver

        2015/4/23 星期四

        10:30 - 12:00 Basic Science Seminar - Liver Tumours Microenvironment and therapy

        ●The inflammatory response and its consequences - can we intervene? Derek Mann, The United Kingdom

        ●The role of neutrophils in HCC Caroline Wilson, The United Kingdom

        ●Oncolytic viral therapy Oliver Ebert, Germany

        ●Targeting, delivery and imaging of oncolytic virotherapeutics Jennifer Altomonte, Germany

        ●Immunotherapy for HCC? David Adams, The United Kingdom

        ●Immune responses to hepatocellular carcinoma: complex regulation and therapeutic potential Ka-Kit Li, The United Kingdom

        2015/4/24 星期五

        7:30 - 8:30 Early Morning Workshops

        Endpoints for antifibrotic trials: what does it take to be a game changer? Moderators: Veronica Miller, The United States;Detlef Schuppan, Germany

        10:30 - 11:00 J.P. Benhamou State of the Art Session

        Iron and the liver…of pathogens, metabolic adaptation and human disease Antonello Pietrangelo, Italy

        12:45-13:45 EASL Recommendations on treatment of hepatitis C 2015

        14:55 - 15:20 Clinical Symposium

        PBCShould we treat PBC as an autoimmune disease? Gideon Hirschfield, The United Kingdom

        2015/4/25 星期六

        10:30 - 11:00 State of the Art Session - Basic Science

        Reengineering the microenvironment to improve treatment of fibrotic diseases Rakesh Jain, The United States

        14:00-15:30 Clinical Symposium HBVFuture of HBV treatments

        ●The current treatment situation and definitions of a cure for chronic HBV infection Geoffrey Dusheiko, The United Kingdom

        ●The main unresolved questions to cure HBV infection Ulrike Protzer, Germany

        ●The new direct antivirals in pre-clinical and early clinical development Fabien Zoulim, France

        ●Novel concepts of immune therapy (restoration of innate and/or adaptive immune responses) Antonio Bertoletti, Singapore

        2015/4/26 星期日

        7:30 - 8:30 WHO Global Hepatitis Strategy in the makingGottfried Hirnschall, Switzerland

        08:30 - 10:00 30 Years of Journal of Hepatology: Emerging issues in HepatologyRajiv Jalan, The United Kingdom